FR2810039B1 - Composes urees cycliques et leur procede de preparation - Google Patents

Composes urees cycliques et leur procede de preparation

Info

Publication number
FR2810039B1
FR2810039B1 FR0007507A FR0007507A FR2810039B1 FR 2810039 B1 FR2810039 B1 FR 2810039B1 FR 0007507 A FR0007507 A FR 0007507A FR 0007507 A FR0007507 A FR 0007507A FR 2810039 B1 FR2810039 B1 FR 2810039B1
Authority
FR
France
Prior art keywords
compounds
carbamic acid
new
function
urea compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0007507A
Other languages
English (en)
French (fr)
Other versions
FR2810039A1 (fr
Inventor
Gilles Guichard
Marc Rodriguez
Serge Plaue
Vincent Semetey
Arnaud Pierre Schaffner
Jean Paul Briand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique
Original Assignee
Centre National de la Recherche Scientifique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0007507A priority Critical patent/FR2810039B1/fr
Application filed by Centre National de la Recherche Scientifique filed Critical Centre National de la Recherche Scientifique
Priority to AU6764501A priority patent/AU6764501A/xx
Priority to IL15340801A priority patent/IL153408A0/xx
Priority to AU2001267645A priority patent/AU2001267645B2/en
Priority to CA2778314A priority patent/CA2778314C/en
Priority to US10/311,178 priority patent/US7186828B2/en
Priority to EP01945420A priority patent/EP1289968B1/fr
Priority to DK01945420T priority patent/DK1289968T3/da
Priority to EP05015015A priority patent/EP1640368A3/fr
Priority to DE60132891T priority patent/DE60132891T2/de
Priority to ES01945420T priority patent/ES2301554T3/es
Priority to KR1020027016995A priority patent/KR20030031001A/ko
Priority to JP2002510461A priority patent/JP5054877B2/ja
Priority to PCT/FR2001/001837 priority patent/WO2001096318A1/fr
Priority to CA2412782A priority patent/CA2412782C/en
Priority to AT01945420T priority patent/ATE386728T1/de
Publication of FR2810039A1 publication Critical patent/FR2810039A1/fr
Application granted granted Critical
Publication of FR2810039B1 publication Critical patent/FR2810039B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/04—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D255/00—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/02—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D255/00—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/04—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D259/00—Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Fats And Perfumes (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR0007507A 2000-06-13 2000-06-13 Composes urees cycliques et leur procede de preparation Expired - Lifetime FR2810039B1 (fr)

Priority Applications (16)

Application Number Priority Date Filing Date Title
FR0007507A FR2810039B1 (fr) 2000-06-13 2000-06-13 Composes urees cycliques et leur procede de preparation
ES01945420T ES2301554T3 (es) 2000-06-13 2001-06-13 Compuestos de ureas ciclicas y su procedimiento de preparacion.
AU2001267645A AU2001267645B2 (en) 2000-06-13 2001-06-13 Cyclic urea compounds and preparation thereof
CA2778314A CA2778314C (en) 2000-06-13 2001-06-13 Cyclic urea compounds and preparation thereof
US10/311,178 US7186828B2 (en) 2000-06-13 2001-06-13 Cyclic urea compounds and preparation thereof
EP01945420A EP1289968B1 (fr) 2000-06-13 2001-06-13 Composes urees cycliques et leur procede de preparation
DK01945420T DK1289968T3 (da) 2000-06-13 2001-06-13 Cykliske urinstofforbindelser og fremgangsmåde til fremstilling heraf
EP05015015A EP1640368A3 (fr) 2000-06-13 2001-06-13 Composés urées cycliques et leur procédé de préparation
AU6764501A AU6764501A (en) 2000-06-13 2001-06-13 Cyclic urea compounds and preparation thereof
IL15340801A IL153408A0 (en) 2000-06-13 2001-06-13 Cyclic urea compounds and preparation thereof
KR1020027016995A KR20030031001A (ko) 2000-06-13 2001-06-13 사이클릭 우레아 화합물 및 그의 제조방법
JP2002510461A JP5054877B2 (ja) 2000-06-13 2001-06-13 環式尿素化合物及びその調製方法
PCT/FR2001/001837 WO2001096318A1 (fr) 2000-06-13 2001-06-13 Composes urees cycliques et leur procede de preparation
CA2412782A CA2412782C (en) 2000-06-13 2001-06-13 Cyclic urea compounds and preparation thereof
AT01945420T ATE386728T1 (de) 2000-06-13 2001-06-13 Zyklische harnstoffverbindungen und verfahren zu deren herstellung
DE60132891T DE60132891T2 (de) 2000-06-13 2001-06-13 Zyklische harnstoffverbindungen und verfahren zu deren herstellung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0007507A FR2810039B1 (fr) 2000-06-13 2000-06-13 Composes urees cycliques et leur procede de preparation

Publications (2)

Publication Number Publication Date
FR2810039A1 FR2810039A1 (fr) 2001-12-14
FR2810039B1 true FR2810039B1 (fr) 2007-05-25

Family

ID=8851208

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0007507A Expired - Lifetime FR2810039B1 (fr) 2000-06-13 2000-06-13 Composes urees cycliques et leur procede de preparation

Country Status (13)

Country Link
US (1) US7186828B2 (enExample)
EP (2) EP1640368A3 (enExample)
JP (1) JP5054877B2 (enExample)
KR (1) KR20030031001A (enExample)
AT (1) ATE386728T1 (enExample)
AU (2) AU6764501A (enExample)
CA (2) CA2412782C (enExample)
DE (1) DE60132891T2 (enExample)
DK (1) DK1289968T3 (enExample)
ES (1) ES2301554T3 (enExample)
FR (1) FR2810039B1 (enExample)
IL (1) IL153408A0 (enExample)
WO (1) WO2001096318A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602006016168D1 (de) * 2005-12-29 2010-09-23 Immupharma France Sa 1,3,5-triazepin-dionen zur Behandlung von Malaria
AU2006331355B2 (en) * 2005-12-29 2011-09-29 Immupharma France Sa Compositions and methods for the inhibition of phospholipase A2
US7777030B2 (en) 2005-12-29 2010-08-17 Centre National de la Recherge Scientifique (CNRS) Compositions and methods for the treatment and prevention of disease
AU2006331357B2 (en) * 2005-12-29 2012-05-17 Immupharma France Sa Compositions and methods for synthesizing novel heterocyclic therapeutics
JP2009522236A (ja) * 2005-12-29 2009-06-11 イミュファルマ・フランス・エスアー マラリアまたはエイズの処置のためのアザ複素環化合物
US8563115B2 (en) 2008-08-12 2013-10-22 Xerox Corporation Protective coatings for solid inkjet applications
US8191992B2 (en) * 2008-12-15 2012-06-05 Xerox Corporation Protective coatings for solid inkjet applications
EP2548869A1 (en) * 2011-07-20 2013-01-23 Cytec Technology Corp. Process for the Synthesis of N-substituted Cyclic Alkylene Ureas
CN102911130B (zh) * 2011-08-03 2015-05-20 北京师范大学 一种一锅法合成脲四元环化合物的方法、合成的脲四元环化合物
EP3640263A1 (en) 2013-08-21 2020-04-22 UREKA Sarl Peptide-oligourea chimeric compounds and methods of their use
WO2016207726A1 (en) 2015-06-22 2016-12-29 Ureka Sarl Bioinspired catalysis using oligourea helical foldamers
WO2017037142A1 (en) 2015-08-31 2017-03-09 Centre National De La Recherche Scientifique (Cnrs) Foldamer helix bundle-based molecular encapsulation
AU2017252015A1 (en) 2016-04-19 2018-11-08 Ureka Sarl Peptide-oligourea foldamer compounds and methods of their use
US12434075B2 (en) * 2021-05-11 2025-10-07 Celestial Oncology Inc. Coupled robotic radiation therapy system

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2847760A1 (de) * 1978-11-03 1980-05-14 Hoechst Ag Verfahren zur herstellung von 1,3,5-triaza-2,4,6-triketo-cycloheptan- 3,5-di-essigsaeureestern
US4918186A (en) * 1986-05-06 1990-04-17 Mitsui Toatsu Chemicals, Inc. Process for producing cyclic ureas
KR100268694B1 (ko) * 1991-10-11 2000-10-16 미리암 디. 메코너헤이, 블레어큐. 퍼거슨 레트로바이러스 프로테아제 억제제로 유용한 시클릭 우레아 및 유사체
US5610294A (en) * 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
US5637780A (en) 1993-03-30 1997-06-10 The Dupont Merck Pharmaceutical Company Method for preparing alkylating agents and their use for alkylating cyclic ureas
US5508400A (en) * 1994-04-20 1996-04-16 The Du Pont Merck Pharmaceutical Company Preparation of cyclic urea compounds
AU5310096A (en) * 1995-03-17 1996-10-08 Du Pont Merck Pharmaceutical Company, The Cyclic urea hiv protease inhibitors
US5532356A (en) * 1995-06-06 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N,N'-disubstituted cyclic ureas
US5532357A (en) * 1995-06-07 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas
WO1997008150A1 (en) 1995-08-22 1997-03-06 The Du Pont Merck Pharmaceutical Company Substituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitors
NZ335919A (en) 1996-11-08 2000-09-29 Du Pont Pharm Co (4r,5s,6s,7r)-hexahydro-1-[5-(3-aminoinazole)methyl]-3-butyl-5 ,6-dihydroxy-4,7-bis[phaenylmethyl]-2h-1,3-diazepin-2-one, its preparation and its use as hiv protease inhibitor

Also Published As

Publication number Publication date
DE60132891D1 (de) 2008-04-03
US20040044199A1 (en) 2004-03-04
KR20030031001A (ko) 2003-04-18
WO2001096318A1 (fr) 2001-12-20
JP2004503546A (ja) 2004-02-05
AU2001267645B2 (en) 2006-07-27
ES2301554T3 (es) 2008-07-01
CA2412782C (en) 2012-08-07
DE60132891T2 (de) 2009-03-19
JP5054877B2 (ja) 2012-10-24
EP1289968A1 (fr) 2003-03-12
CA2778314C (en) 2017-01-03
FR2810039A1 (fr) 2001-12-14
AU6764501A (en) 2001-12-24
CA2778314A1 (en) 2001-12-20
IL153408A0 (en) 2003-07-06
WO2001096318A8 (fr) 2003-05-01
EP1640368A2 (fr) 2006-03-29
ATE386728T1 (de) 2008-03-15
CA2412782A1 (en) 2001-12-20
EP1289968B1 (fr) 2008-02-20
US7186828B2 (en) 2007-03-06
DK1289968T3 (da) 2008-06-23
EP1640368A3 (fr) 2007-03-28

Similar Documents

Publication Publication Date Title
IL153408A0 (en) Cyclic urea compounds and preparation thereof
FI950650A0 (fi) Retrovirusproteaasi-inhibiittoreina käyttökelpoisia hydroksietyyliaminosulfoniamideja
DK0696280T3 (da) Substituerede pyrrolidin-3-yl-alkyl-piperidiner anvendelige som tachykinin-antagonister
ATE293127T1 (de) Synthetische peptidinhibitoren der hiv- übertragung
ATE155486T1 (de) Zyklische peptide und ihre verwendung
MY125555A (en) Heptapeptide oxytocin analogues
ATE245435T1 (de) Totalsynthese des amino hip analogen von didemnin a
TR200000993T2 (tr) Endotelin antagonistleri.
WO2001051673A8 (en) Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission
SE9903291D0 (sv) New process
DE3850550D1 (de) Dipeptide, verwendbar als Pflanzenwachstumsregulatoren.
ES2175328T3 (es) Piperidonas como antagonistas de la taquiquinina.
AU5628990A (en) Enzyme inhibitors
CA2093202A1 (en) Sterilant gas mixture
EA200201003A1 (ru) Аморфная модификация торасемида
WO2001014576A3 (en) Process and intermediates for the preparation of isoxazolecaroxamides and analogues
SE9800865D0 (sv) New Process
NZ508812A (en) Peptides for the prevention or treatment of HIV
NZ506667A (en) A process for the conversion of echinocandin class of peptides to their c4-homotyrosine monodeoxy analogues
WO2004029081A3 (en) Modified glp-1 peptides with increased biological potency
NO952748D0 (no) Polypeptid som spesifikt inhiberer Cathepsin L.
MX9710225A (es) Inhibidores calpaina para el tratamiento de enfermedades neurodegenerativas.
NO20004278L (no) Fremstilling av 2-oksopiperaziner pÕ en fast bærer
WO1999060117A3 (fr) Polypeptide prax-1
IT1317000B1 (it) Uso di composti di origine naturale ad attivita' antiangiogenica.

Legal Events

Date Code Title Description
AU Other action affecting the ownership or exploitation of an industrial property right
CL Concession to grant licences
CD Change of name or company name
TQ Partial transmission of property
PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20